Peripartum cardiomyopathy (PPCM) is defined as the development of heart failure in the last trimester of pregnancy or up to the sixth postpartum month. There is absence of demonstrable heart disease prior to the last trimester and no aetiology can be found.l'2
Case report A 29-year-old G2 PI presented for an elective repeat Caesarean section at term. Past obstetric history revealed a first pregnancy three years earlier, complicated by pre-eclampsia which necessitated an urgent delivery by Caesarean section, under epidural anaesthesia. After delivery of a healthy male infant, general anaesthesia was induced, as the patient had a grand mal seizure, for undetermined reasons. Twenty-four hours after delivery, after uneventful recovery from the anaesthetic, the patient developed pulmonary oedema which responded to medical therapy, Chest x-ray at that time revealed global cardiac enlargement and an echocardiogram showed a dilated, hypocontractile left ventricle with a thin, hypokinetic interventricular septum. No cause for the sudden onset of heart failure could be determined and the patient was discharged from hospital on the seventh postoperative day, under the care of a cardiologist.
In the interim, the patient remained asymptomadc but serial echocardiograms taken during this period demonstrated persistent left ventricular dilatation and mild impairment of myocardial contractility. Her ECG was normal apart from frequent asymptomatic uniform ventricu]ar premature depolarisations. Physical examination was unremarkable and she was normotensive.
The repeat Caesarean section was performed under epidural anaesthesia using incremental boluses of carbonated lidoeaine (two per cent) with 1:400,000 epinephrine to a total of 15 ml.min -t via an epidural catheter inserted at the L2_3 interspace. She was given 6 L'min-t of oxygen by mask and positioned with a left lateral tilt of the uterus.
Prior to this, a Cordis | introducer had been placed via the right internal jugular vein. The initial CVP was 4cm H20. Routine monitors included ECG (modified V S configuration) and an automatic blood pressure device. In our institution non-invasive haemodynamic data are obtained from an impedance cardiograph, the NCCOM3 Surgery and anaesthesia were uneventful, although the mean BP fell approximately ten minutes after delivery due to a reduction in SVR, with no significant fall in cardiac output. This responded to intravenous ephedrine in two 5 mg boluses and an increase in the rate of infusion of intravenous saline to achieve a CVP of 8 cm H20 (Table  1) . "lhe patient made a good recovery postoperatively and a five-month follow-up showed her to be clinically well with normal LV dimensions on echocardiogram
Discussion
Four excellent reviews of PPCM have been published in the last three years. ]'2'6'7 The incidence of PPCM is between 1:1300 to 1:4000 live births in the U,S.A., with an overall mortality rate of 25-50 per cent. 2 Morbidity and mortality rates can be even higher in subsequent pregnancies if the LV dimensions have not normalised between six to 12 months post partum, s.9 Those patients with a return to normal LV size have only a 25 per cent chance of developing pulmonary oedema in subsequent pregnancies, with a negligible mortality rate. s Those patients with persistent cardiomegaly at the onset of their next pregnancy show a 60 per cent mortality and 80 per cent morbidity rate.I Even though most of these figures come from studies looking at patients from low socioeconomic groups with inadequate antenatal care, the numbers are comparable with recently published data of middle class women who had excellent antenatal care and card [ological evaluation. 7 In light of these facts it was felt that our patient would be at risk throughout the delivery period. Most pregnant women show a volume-loading phenomenon of pregnancy seen as right ventricular dilatation on echocardiogram, but significant left ventricular dilatation, especially in the late post partum period, is considered to be abnormal.
A diagnosis of PPCM can only be made after excluding the other causes of acute heart failure. The differential diagnosis includes non-cardiac causes such as toxaemia (pre-eclampsia), l~ betaz-adrenergic tocolysis,tl pulmonary embolism, amniotie fluid embolism n and aspiration pneumonitis. Cardiac causes include decompensated valvular and subvalvular disease, myocardial ischaemia and infarction, fluid overload and cardiomyopathy.
A decision to use regional anaesthesia for surgery was made in order to avoid potentially cardiodepressant general anaesthetic agents and perhaps allow an earlier diagnosis of cardiovascular compromise in the awake patient.
The choice of a non-invasive technique for following cardiac output was made because of concern for subjecting an otherwise healthy mother and her fetus to the potential risks of invasive monitoring with a Swan Ganz catheter (SGC). t3 t5
Adequate management of the haemodynamic alterations that may occur during surgery requites vigilant attention to patient response and appropriate monitoring aids. In this case, the patient with only mild impairment of LV function can be satisfactorily monitored non-invasivcly and the trends in cardiac output provide us with an excellent overall picture of cardiac function. Wc do not feel it is necessary to "'fine tune" or maximise cardiac output by manipulating pulmonary capillary wedge pressure (PCWP) if our baseline cardiac output is satisfactory and the patient falls within the categories listed in Table  II .
Elective use of invasive monitoring is justified in a symptomatic patient with an elevated JVP, third and fourth heart sounds, orthopnoea, PND or shortness of breath at rest, with clinical evidence of a low cardiac output or echoeardiographic evidence of significant myocardial depression (poor contractility, LV wall motion abnormalities) (Table IIi) . Non-invasive monitoring can be achieved using a Doppler technique but this is not without its technical difficulties, is The impedance technique produces reliable trends in various haemodynamic parameters and has allowed confident, successful management of severe pre-eclampsia in our institution. This approach is far more acceptable to our patients and when they are asymptomatic, well controlled epidural anaesthesia and non-invasive monitoring provides optimal management with a minimal risk/benefit ratio.
Toxaemia of pregnancy can complicate 15-30 per cent of pregnancies associated with PPCM which is an incidence four times higher than in the normal pregnant population. 17 It is not known whether this relationship is coincidental or cause-and-effect, but it is likely to worsen the prognosis of PPCM due to an increased afterload further straining an already weakened myocardium. The presence of toxaemia in a patient with PPCM will thus favour an invasive approach, using a SGC. Even so, a study by Benedett~ has shown that PCWP correlates well with CVP when the latter is less than 6 cm HzO. to This patient had an uneventful course, but had deeompensation Pulmonary oedema in the pefipartum period should never be treated lightiy. All pregnant patients who have unexplained congestive heart failure should receive appropriate therapy and, when stable, undergo diagnostic echocardiography and complete assessment by a cardiologist. Some of the causes are treatable and some patients will show mural thrombi requiring long-term anticoagulation. ~8
A recent report describing two cases of pulmonary oedema associated with Caesarean section reminds us that the risk to our patients with PPCM is real. 19 It must be stressed that invasive monitoring is not always required and each case must be assessed individually and appropriate monitors selected accordingly.
It is of interest that five months after her second delivery the long standing ventricular dilatation had returned to normal. We are not aware of any report of a successful delivery significantly reducing LV size as rapidly as that seen in this patient.
Conclusion
PPCM is a diagnosis made by exclusion but should never be regarded as insignificant. Follow-up by a cardiologist with serial echocardiography is essential. Anaesthetic management and appropriate haemodynamic monitoring is aimed at optimising fluid therapy, avoiding cardiodepressant drugs and providing a minimal risk/benefit ratio to both mother and fetus with a well controlled epidural anaesthetic.
Choice of monitors will depend on the severity of the myocardial disease and degree of symplomatolo~y, Persistent LV dilatation at the onset of subsequent pregnancies carries a higher morbidity and mortality incidence. If the patient is asymptomatic, non-invasive haemodynamic monitoring can provide a safe, reliable means of following the cardiopulmonary status of the patient.
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